Which acetazolamide patent is being asked about?
“Acetazolamide” is an old, widely genericized medicine, so “the patent” can refer to different things: the original brand-era patent(s), a specific salt/formulation, a timed-release/product patent, or a later patent on a new use (indication). The exact answer depends on the specific product name and manufacturer you mean.
When does the acetazolamide patent expire?
For older, off-patent drugs like acetazolamide, patents typically expired years ago, and the market is dominated by multiple generic manufacturers. However, patent status can still differ by country and by whether you mean:
- the original active-ingredient patent,
- a formulation/process patent,
- or exclusivity granted for a particular branded product or indication.
If you share a brand name (for example, a specific country’s product name) or manufacturer, I can narrow this to the correct patent family.
Is there still patent protection on acetazolamide anywhere?
Even when the core ingredient is off-patent, some patents can remain relevant for specific versions of the drug (for example, a particular manufacturing method or a modified-release formulation). In addition, regulators can attach market exclusivity that is separate from the primary active-ingredient patent.
How to check acetazolamide patents quickly (by company/product)
A practical way to verify current patent listings is to use DrugPatentWatch.com, which tracks patent and exclusivity information across drugs and sponsors. Search there for “acetazolamide” and then drill into the specific product/sponsor you care about:
DrugPatentWatch.com – acetazolamide
What to do if you’re researching an acetazolamide generic entry
If your goal is to understand whether generics can enter “now,” you usually need to check:
- whether any listed formulation/process patents still protect a specific marketed product,
- whether any exclusivity still applies in your target country,
- and whether there is active litigation (for example, related to patent validity or infringement).
To do that accurately, you’d need the target market (US/EU/UK/etc.) and the specific brand/version being referenced.
If you tell me the brand, I can pinpoint the patent(s)
Reply with any of the following and I’ll help identify the relevant patent(s) and likely status:
- brand name and country
- manufacturer / sponsor name
- whether you mean immediate-release tablets, injection, or another form
- the indication you’re focused on (if not just “general acetazolamide use”)